Autoimmune hemolytic anemia primary prevention

	Autoimmune hemolytic anemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune hemolytic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Autoimmune hemolytic anemia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune hemolytic anemia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune hemolytic anemia primary prevention
CDC on Autoimmune hemolytic anemia primary prevention
Autoimmune hemolytic anemia primary prevention in the news
Blogs on Autoimmune hemolytic anemia primary prevention
Directions to Hospitals Treating Autoimmune hemolytic anemia
Risk calculators and risk factors for Autoimmune hemolytic anemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Irfan Dotani

Overview

The primary prevention strategies for autoimmune hemolytic anemia include avoidance of exposure to precipitants.

The primary prevention strategies for autoimmune hemolytic anemia include:

Avoidance of exposure to infectious agents or medications that are known to be associated with autoimmune hemolytic anemia.^[1]
- For example, avoidance of Mycoplasma via routine hand hygiene and avoidance of sick contacts is a primary prevention strategy.